P

Pontificia Universidad Catolica de Chile | Centro de Investigacion Clinica UC-CICUC

Research site
(Unclaimed)
Location
Portugal 61 piso 1, Santiago, Santiago, Chile
Site insights

Top conditions

Depression (3 trials)

Neuralgia (3 trials)

Stroke (2 trials)

Gaucher Disease (2 trials)

Hypertension (2 trials)

Top treatments

Epinephrine
Levobupivacaine
Fentanyl
UDCA
BMS-986360
Doxorubicin
BMS-986165
Seralutinib
Pembrolizumab
Leuprolide Acetate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 46
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors

The aim of this study is to assess the safety and tolerability of BMS-986360 as monotherapy and in combination with chemotherapy or nivolumab in part...

Enrolling
Advanced Solid Tumors
Drug: Capecitabine
Drug: Docetaxel

This multicenter, open-label, single-arm trial will evaluate the anti-tumor activity of ZW25 (zanidatamab) monotherapy in subjects with human epiderm...

Active, not recruiting
HER2-amplified Biliary Tract Cancers
Drug: ZW25 (Zanidatamab)

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Other: Placebo
Drug: Deucravacitinib

This is a placebo-controlled study to evaluate the addition of CAL02 to standard of care in treating hospitalized subjects diagnosed with severe comm...

Enrolling
Pneumonia, Bacterial
Drug: Placebo
Drug: CAL02

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are...

Enrolling
Pulmonary Arterial Hypertension
Drug: Seralutinib
Device: Generic Dry Powder Inhaler

The primary objectives of this study are to compare MK-2870 to Treatment of Physician's Choice (TPC) with respect to progression-free survival (PFS)...

Enrolling
Endometrial Cancer
Biological: MK-2870
Drug: Doxorubicin

The purpose of this study was to evaluate the efficacy and safety of pembrolizumab plus epacadostat compared to sunitinib or pazopanib in participant...

Active, not recruiting
Renal Cell Carcinoma (RCC)
Drug: Pazopanib
Drug: Epacadostat

Trial sponsors

P

Pontificia Universidad Catolica de Chile (20 trials)

Bristol-Myers Squibb (BMS) logo

Bristol-Myers Squibb (BMS) (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems